FDA cites dangers of using injectable glutathione as skin lightener

The Food and Drug Administration (FDA) on Monday warned the public against the possible dangers of using injectable glutathione as skin lightening agent amid the trend of administering intravenous drips in beauty salons, wellness spas, and beauty clinics.

“To date there are no published clinical trials that have evaluated the use of injectable glutathione for skin lightening. There are also no published guidelines for appropriate dosing regimens and duration of treatment,” it said in an advisory.

“The FDA has not approved any injectable products for skin lightening. Injectable glutathione is approved by FDA Philippines as an adjunct treatment in cisplatin chemotherapy,” it added.

Its side effects may damage the liver, kidney, and nervous system of the user, according to the FDA.

It also raised the possibility of contracting Stevens Johnson Syndrome.

The “theoretical concerns” on long-term skin cancer risk was also cited by the FDA as melanin production is affected by glutathione.

The transmission of HIV, and Hepatitis B and C is also a potential risk if this treatment is done in non-sterile facilities and administered by non-medical practitioners, the FDA further warned.

“To assure that your skin conditions are treated, consult only a board-certified dermatologist. Avoid buying injectable products online and from being lured to a promising effect of medicines as beauty products,” the FDA said.

It also advised users who are experiencing those side effects to immediately consult a doctor. —VDS, GMA News